Oliver Lagore Vanvalin Investment Group’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$811K Buy
+5,520
New +$774K 0.32% 70
2024
Q4
$1.08M Buy
8,210
+1,622
+25% +$227K 0.28% 70
2024
Q3
$1.03M Buy
6,588
+814
+14% +$131K 0.27% 71
2024
Q2
$901K Sell
5,774
-815
-12% -$123K 0.26% 68
2024
Q1
$893K Buy
6,589
+6,582
+94,029% +$872K 0.27% 69
2023
Q4
$943 Sell
7
-41
-85% -$5.33K ﹤0.01% 664
2023
Q3
$6.51K Sell
48
-42
-47% -$5.74K ﹤0.01% 511
2023
Q2
$12.9K Buy
90
+24
+36% +$3.53K ﹤0.01% 427
2023
Q1
$9.1K Buy
66
+2
+3% +$269 ﹤0.01% 396
2022
Q4
$8.68K Buy
64
+49
+327% +$6.14K 0.01% 380
2022
Q3
$2K Hold
15
﹤0.01% 515
2022
Q2
$2K Buy
15
+8
+114% +$1.05K ﹤0.01% 485
2022
Q1
$1K Buy
+7
New +$839 ﹤0.01% 524

Other funds holding AZN